The Complete Guide to ICD-10 Codes for MRSA

In the intricate dance of modern medicine, two powerful forces are in constant interplay: the biological reality of disease and the structured language we use to describe it. Few adversaries exemplify this clash more than Methicillin-Resistant Staphylococcus aureus (MRSA), a formidable pathogen that has evolved to defy our first-line defenses. Its presence in a healthcare setting is a call to action, triggering isolation protocols, complex treatment regimens, and heightened vigilance. But how does this clinical reality translate into the alphanumeric lexicon that drives healthcare administration, finance, and public health? The answer lies in the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM).

Accurate ICD-10 coding for MRSA is not a mere clerical task; it is a critical competency that sits at the intersection of clinical care, financial sustainability, and epidemiological science. A single code can influence a patient’s diagnosis-related group (DRG), altering hospital reimbursement by thousands of dollars. It can flag a case for infection control teams, prompting interventions to prevent an outbreak. It can provide vital data to public health organizations tracking the spread of antimicrobial resistance. This article serves as a definitive guide for medical coders, health information management (HIM) professionals, clinicians, and healthcare administrators seeking to master the nuances of MRSA coding. We will move beyond basic definitions into the complex scenarios and documentation challenges that define real-world practice, ensuring that the story told by the medical record is accurately reflected in the codes that follow.

2. Understanding the Adversary: A Primer on Staphylococcus aureus and MRSA

To code a condition accurately, one must first understand its clinical nature. MRSA is not a distinct disease but a specific characteristic of a common bacterium.

From Commensal to Pathogen: The Life of S. aureus

Staphylococcus aureus is a gram-positive bacterium that is a frequent resident on the skin and in the nasal passages of approximately 30% of the population. In this state, it is a commensal organism, living in harmony with its host without causing disease. However, S. aureus is an opportunistic pathogen. When the skin barrier is compromised by a cut, surgical wound, intravenous catheter, or other means, the bacterium can invade underlying tissues, leading to a spectrum of infections. These range from minor skin and soft tissue infections (e.g., boils, impetigo, folliculitis) to life-threatening conditions such as pneumonia, bacteremia, endocarditis, and osteomyelitis.

The Rise of Resistance: How MRSA Outsmarts Antibiotics

The discovery of penicillin in the 1940s provided an effective weapon against S. aureus. However, the bacterium’s remarkable ability to adapt led to the rapid emergence of penicillin-resistant strains. Methicillin, a semi-synthetic penicillinase-resistant antibiotic, was introduced in 1959 to counter this resistance. Tragically, within two years, the first strains of Methicillin-Resistant Staphylococcus aureus (MRSA) were identified.

MRSA’s resistance is conferred by the mecA gene, which codes for an altered penicillin-binding protein (PBP2a). This protein has a low affinity for beta-lactam antibiotics, including all penicillins, cephalosporins, and carbapenems. Consequently, these first-line antibiotics cannot bind effectively to the bacterial cell wall, rendering them useless. Treating MRSA infections requires alternative, often more expensive and potentially more toxic, antibiotics such as vancomycin, linezolid, or daptomycin.

The Clinical Spectrum: Colonization vs. Active Infection

This is the most critical distinction for coding purposes.

• Colonization: This occurs when MRSA is present on or in the body (e.g., in the nose, on the skin, in the throat) without causing any signs or symptoms of illness. The individual is a “carrier” and can potentially transmit the bacteria to others, but they are not sick from it.

• Active Infection: This occurs when MRSA has invaded the body and is causing a clinically apparent illness, such as pus-filled wounds, fever, chills, or signs of specific organ involvement.

The clinical approach and the ICD-10 code assigned are entirely dependent on which of these states is documented.

3. The Foundation of Medical Coding: An Overview of the ICD-10-CM System

The ICD-10-CM is the official system for assigning codes to diagnoses and procedures in the United States. It is maintained by the Centers for Disease Control and Prevention (CDC) and the Centers for Medicare & Medicaid Services (CMS).

Purpose and Structure: More Than Just Numbers

The system serves multiple vital functions:

• Standardization: It provides a universal language for diseases, conditions, and reasons for encounters with the healthcare system.

• Reimbursement: It is the primary driver of diagnosis-related groups (DRGs) and other payment models, determining how much a provider is paid for a patient’s care.

• Public Health: It enables the tracking of disease prevalence, outbreaks, and mortality rates, informing public health policy and research.

• Research: Aggregated coded data is used for clinical, epidemiological, and health services research.

ICD-10-CM codes are alphanumeric, ranging from 3 to 7 characters. The structure is hierarchical:

• Chapter: The first character is a letter, representing a broad chapter (e.g., Chapter 1: Certain Infectious and Parasitic Diseases, Codes A00-B99).

• Category: The first three characters (e.g., B95) define the general category of the disease.

• Subcategory and Extension: Characters four through seven provide increasing levels of detail regarding etiology, anatomical site, severity, and other specifics.

The Importance of Specificity in Modern Healthcare

ICD-10-CM’s granularity is its defining feature. Unlike its predecessor, ICD-9-CM, it demands precise clinical details. For MRSA, this means coding not just that an infection exists, but its role (cause vs. carrier), its location, and its acuity. This specificity is crucial for accurate reimbursement, as more severe and complex conditions generally command higher payment rates. It also provides a richer, more accurate dataset for quality measurement and outcomes research.

4. Decoding the Codes: The ICD-10-CM Index for MRSA

The coding process begins with the Alphabetic Index. For MRSA, there are two primary paths.

The Primary Entry: Navigating from “MRSA” and “Staphylococcus”

A coder would look up:

• MRSA: The index entry for “MRSA” typically directs the user to see Staphylococcus, aureus, methicillin resistant. This reinforces that MRSA is a type of Staphylococcus aureus.

• Staphylococcus: Following this path is essential.

  • Staphylococcus

  • -> aureus

  • -> methicillin resistant -> This leads to two primary options:

    • as cause of disease classified elsewhere -> B95.62

    • carrier or suspected carrier of -> Z22.322

Understanding the Tabular List: The Final Authority

The Alphabetic Index provides a roadmap, but the Tabular List is the law. One must never code directly from the index. The codes identified must be verified in the Tabular List, where all inclusion and exclusion notes, as well as instructional notes, are located.

5. A Deep Dive into Code Z22.322: Carrier of MRSA (Colonization)

Code: Z22.322 – Carrier or suspected carrier of Methicillin resistant Staphylococcus aureus

This code is used when a patient has documented MRSA colonization but no active infection. It is a status code from Chapter 21 (Factors Influencing Health Status and Contact with Health Services).

Clinical Scenarios and Documentation Requirements

This code is assigned in situations such as:

• A pre-admission nasal swab for a scheduled surgery comes back positive for MRSA.

• A patient is admitted from a nursing home with a known history of MRSA colonization, documented in the transfer records, and is placed in contact isolation upon admission, but has no signs of infection.

• A routine screen of a healthcare worker reveals MRSA colonization.

Documentation is Key: The medical record must clearly state “MRSA colonization,” “MRSA positive,” “MRSA carrier,” or similar phrasing. The mere presence of an “Isolation” order is not sufficient, as isolation can be initiated for other reasons.

The Critical Distinction: Carrier Status vs. Personal History

This is a nuanced but vital difference.

• Z22.322 (Carrier): Used when the patient is currently colonized. The bacteria are present on the body at the time of the encounter.

• Z86.14 (Personal history of methicillin resistant Staphylococcus aureus): Used when a patient had a past MRSA infection or colonization that has since been eradicated (e.g., after decolonization therapy) and is no longer present. The problem is resolved, but the history is relevant to the patient’s care.

Sequencing and Reporting with Other Codes

Z22.322 is generally sequenced as a secondary code. The primary reason for the encounter is coded first. For example:

• A patient is admitted for a total hip replacement (primary diagnosis) and is found to be an MRSA carrier.

  • Primary Code: The code for the hip osteoarthritis requiring replacement.

  • Secondary Code: Z22.322

  • This sequencing accurately reflects that the surgery is the reason for admission, and the MRSA status is a complicating factor influencing the care plan (e.g., may prompt use of vancomycin for surgical prophylaxis).

6. Navigating Active MRSA Infections: The B95.62 Code

Code: B95.62 – Methicillin resistant Staphylococcus aureus as the cause of diseases classified elsewhere

This code is from Chapter 1 (Certain Infectious and Parasitic Diseases) and is part of a block of codes (B95-B97) used to identify infectious agents. Crucially, codes from B95-B97 are never to be used as a principal/first-listed diagnosis.

The “Code First” Rule: A Non-Negotiable Guideline

The instructional note under category B95 in the Tabular List explicitly states: “Code first the disease caused by the bacteria, such as: sepsis (A41.0-).” This means:

1. You must first identify and code the specific infection that MRSA is causing (e.g., pneumonia, cellulitis, sepsis).

2. Then, you assign B95.62 as a secondary code to specify that the causative agent is MRSA.

Illustrative Case Studies: Pneumonia, Sepsis, Cellulitis, and Osteomyelitis

Case Study 1: MRSA Pneumonia

• Scenario: A patient presents with fever, cough, and shortness of breath. A chest X-ray confirms pneumonia, and sputum cultures grow MRSA.

• Documentation: “Community-acquired pneumonia due to MRSA.”

• Coding:

  • J15.212 – Pneumonia due to Methicillin resistant Staphylococcus aureus

  • B95.62 – Methicillin resistant Staphylococcus aureus as the cause of diseases classified elsewhere

• Rationale: The code J15.212 already specifies the organism as MRSA. However, coding B95.62 in addition is a best practice recommended by many experts and encoder systems to fully capture the etiology and ensure data integrity for infection tracking.

Case Study 2: MRSA Sepsis

• Scenario: A patient is admitted with fever, hypotension, and altered mental status. Blood cultures return positive for MRSA.

• Documentation: “Sepsis due to Methicillin-resistant Staphylococcus aureus.”

• Coding:

  • A41.02 – Sepsis due to Methicillin resistant Staphylococcus aureus

  • B95.62 – Methicillin resistant Staphylococcus aureus as the cause of diseases classified elsewhere

• Rationale: Similar to pneumonia, A41.02 is specific to MRSA sepsis. The dual coding with B95.62 reinforces the causative agent.

Case Study 3: MRSA Cellulitis

• Scenario: A patient has a swollen, red, and painful wound on their leg. Wound culture confirms MRSA.

• Documentation: “Cellulitis of right lower leg due to MRSA.”

• Coding:

  • L03.115 – Cellulitis of right lower limb

  • B95.62 – Methicillin resistant Staphylococcus aureus as the cause of diseases classified elsewhere

• Rationale: The code for cellulitis (L03.115) does not specify the organism. Therefore, B95.62 is mandatory to identify MRSA as the cause. This dramatically impacts DRG assignment and reimbursement.

The Concept of Causality and Provider Documentation

The coder can only assign B95.62 if the provider has explicitly linked the infection to MRSA. If the culture report is positive for MRSA but the provider’s diagnosis only states “cellulitis,” the coder cannot assume causality. In such cases, a physician query is essential to clarify the diagnosis.

7. Special Circumstances and Complex Coding Scenarios

MRSA in the Context of Sepsis and Septic Shock

This is a high-stakes coding scenario. The hierarchy is critical:

1. Code for the systemic infection: R65.20 (Severe sepsis without septic shock) or R65.21 (Septic shock).

2. Code for the underlying infection: A41.02 (Sepsis due to MRSA).

3. Code for any acute organ dysfunction(s) (e.g., Acute kidney failure, Hepatic failure, Encephalopathy).

4. Code the causative agent: B95.62 (MRSA).

Postprocedural and Surgical Site Infections

If a patient develops an MRSA infection after a procedure, two codes are required:

1. A code from T81.4- (Infection following a procedure) or T84.5- (Infection and inflammatory reaction due to internal joint prosthesis) or other specific complication codes.

2. B95.62 to identify the organism.
   An additional code from the Chapter 19 (Injury, poisoning, and certain other consequences of external causes) may be needed to identify the specific site of the infection.

MRSA Pneumonia: Community-Acquired vs. Hospital-Acquired

While the ICD-10 code J15.212 is the same, the Present on Admission (POA) indicator is used to distinguish between community-acquired and hospital-acquired cases for quality reporting and reimbursement purposes. A “N” for “No” on the POA indicator for J15.212 would flag it as a hospital-acquired condition (HAC), which can have significant financial implications.

Recurrent Infections and the Role of Personal History Codes (Z86.14)

A patient with a history of a prior MRSA infection who is now being treated for a new, unrelated condition might have Z86.14 (Personal history of MRSA) assigned. This alerts caregivers to the potential for recurrence or colonization, but it is not used if there is a current, active infection.

8. The Critical Role of Documentation and Physician Queries

The coder’s world is defined by the words in the medical record. Incomplete or ambiguous documentation is the primary cause of coding errors and compliance risks.

Elements of Compliant Provider Documentation

For optimal MRSA coding, documentation should include:

• A clear diagnosis: e.g., “MRSA pneumonia,” “Cellulitis due to MRSA.”

• Causality: Linking the organism to the condition.

• Status: Clearly stating “colonized,” “carrier,” or “active infection.”

• Site: The specific anatomical location of the infection.

Crafting Effective and Compliant Queries

When documentation is unclear, a formal physician query is the only compliant path forward. A good query is:

• Non-leading: It should not suggest a specific answer.

• Based on Clinical Evidence: It should reference specific findings in the record (e.g., “The culture from 10/10/2025 is positive for MRSA…”).

• Clear and Concise: It should ask a direct question (e.g., “Can you clarify the causal relationship between the positive MRSA culture and the patient’s diagnosis of pneumonia?”).

9. Compliance, Reimbursement, and the Real-World Impact of Accurate Coding

DRGs, HCCs, and MS-DRGs: The Financial Implications

The addition of a code like B95.62 to a case of cellulitis can shift the DRG from a simpler, lower-paying group to a more complex, higher-paying one. This reflects the increased resource utilization associated with treating a drug-resistant infection (e.g., more expensive antibiotics, longer hospital stays, more intensive monitoring). In the outpatient and physician office setting, Hierarchical Condition Categories (HCCs) used in risk-adjusted payment models like Medicare Advantage are also influenced by accurate diagnosis coding. Reporting a condition like MRSA sepsis (A41.02) contributes to a patient’s risk score, leading to appropriate reimbursement for managing this complex patient.

Public Health Surveillance and Data Integrity

Accurate MRSA coding is the bedrock of public health surveillance. State health departments and the CDC rely on coded data to:

• Track the incidence and prevalence of MRSA infections.

• Identify outbreaks in healthcare facilities or communities.

• Monitor the effectiveness of infection control interventions.

• Guide national policy on antimicrobial stewardship.

The Risks of Miscoding: Denials, Audits, and Fraud

Inaccurate coding has direct consequences:

• Claim Denials: If a code is not supported by documentation, the claim will be denied, resulting in lost revenue.

• Audits: Both internal and external (e.g., from RACs) auditors scrutinize coding. Patterns of errors can lead to large-scale recoupments.

• False Claims Act Liability: Knowingly submitting inaccurate claims can result in severe penalties under the False Claims Act.

10. Future-Proofing Your Coding: Emerging Trends and Technologies

The Transition to ICD-11: What to Expect

The World Health Organization (WHO) has already released ICD-11, which will eventually be adopted in the US as ICD-11-CM. It offers a more modern, digital-friendly structure. While the specific codes will change, the fundamental principles of accurate documentation, specificity, and causal linkage will remain paramount.

The Role of AI and Computer-Assisted Coding (CAC)

CAC software uses natural language processing (NLP) to read clinical documentation and suggest codes. These tools are becoming increasingly sophisticated and can help improve efficiency and accuracy. However, the human coder’s role is evolving to that of a auditor, clinical validator, and expert who understands the nuances and guidelines that AI may miss. The coder remains ultimately responsible for the final code assignment.

11. Conclusion: Mastering the Code for a Microbial Foe

Accurate ICD-10 coding for MRSA is a sophisticated process that demands a deep understanding of clinical medicine, coding guidelines, and documentation standards. The critical distinction between colonization (Z22.322) and active infection (requiring B95.62) forms the foundation of this process. By adhering to the “code first” rule, engaging in compliant physician queries, and appreciating the profound impact of these codes on patient care, reimbursement, and public health, healthcare professionals can ensure they are speaking the language of modern medicine with precision and integrity. In the ongoing battle against antimicrobial resistance, the humble code is a powerful weapon.

12. Frequently Asked Questions (FAQs)

Q1: What is the difference between code B95.62 and a code like J15.212?

• A: B95.62 is an “agent” code that specifies the causative organism (MRSA) but does not describe the disease itself. It must always be used in conjunction with a code for the infection. J15.212 is a “combination” code that describes both the disease (pneumonia) and the specific organism (MRSA). When a combination code exists, it is coded first, and B95.62 can be added as a secondary code for data integrity, though it may not always be required for reimbursement.

Q2: Can I code MRSA based solely on a positive culture result in the lab report?

• A: No. Coders must code based on provider documentation. A positive lab result is clinical evidence, but the physician must incorporate that finding into their diagnostic statement (e.g., “Cellulitis due to MRSA”). If the documentation is unclear, a physician query is necessary.

Q3: A patient is admitted for chemotherapy and has a known history of MRSA colonization. They have no active infection. What code do I use?

• A: The primary code would be for the chemotherapy encounter (Z51.11). Since the patient is a known carrier, you would assign Z22.322 as a secondary diagnosis to explain the need for contact isolation and infection control precautions.

Q4: How do I code a post-operative wound infection confirmed to be MRSA?

• A: This requires multiple codes. You would code first the complication, such as T81.4xxA (Infection following a procedure, initial encounter), followed by the code for the specific type of infection (e.g., L03.211 for cellulitis of abdominal wall, if applicable), and then B95.62 to identify MRSA as the cause.

Q5: When should I use the personal history of MRSA code (Z86.14)?

• A: Use Z86.14 when a past MRSA infection or colonization has been resolved and is no longer present, but the history is relevant to the current care. For example, if a patient had a MRSA joint infection 2 years ago that was successfully treated and they are now being seen for an annual physical, Z86.14 would be appropriate. Do not use it if the patient is a current carrier (use Z22.322) or has an active infection (use B95.62 with the infection code).

13. Additional Resources

• The Official ICD-10-CM Guidelines: Published annually by the CDC and CMS. This is the definitive source for coding rules.

• American Health Information Management Association (AHIMA): Offers a wealth of resources, including practice briefs, articles, and education on coding best practices.

• Centers for Disease Control and Prevention (CDC) – MRSA Website: Provides up-to-date clinical information, statistics, and infection control guidelines for MRSA.

• AHA Coding Clinic for ICD-10-CM/PCS: The official source for coding advice and guidance. It provides authoritative answers to specific coding questions, including many related to MRSA and other infections.

• The Society for Healthcare Epidemiology of America (SHEA): Provides clinical guidance on the management of multidrug-resistant organisms, including MRSA.

Date: October 12, 2025
Disclaimer: The information contained in this article is for educational and informational purposes only and is not intended as a substitute for professional medical coding, billing, or legal advice. Medical coding guidelines are subject to change. Always consult the most current official ICD-10-CM coding manuals, guidelines, and your organization’s compliance officer for specific coding scenarios.